SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K/A - Current report: [Amend]
SEC Accession No. 0001437749-13-000854
Filing Date
2013-01-30
Accepted
2013-01-30 06:45:32
Documents
3
Period of Report
2013-01-30
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K/A pdl_8ka-013013.htm 8-K/A 28711
2 EXHIBIT 99.1 ex99-1.htm EX-99.1 7096
3 logo.jpg GRAPHIC 7764
  Complete submission text file 0001437749-13-000854.txt   47935
Mailing Address 932 SOUTHWOOD BLVD INCLINE VILLAGE NV 89451
Business Address 932 SOUTHWOOD BLVD INCLINE VILLAGE NV 89451 775-832-8500
PDL BIOPHARMA, INC. (Filer) CIK: 0000882104 (see all company filings)

IRS No.: 943023969 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K/A | Act: 34 | File No.: 000-19756 | Film No.: 13556972
SIC: 2836 Biological Products, (No Diagnostic Substances)